Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer

Author:

Zou Jiachen12ORCID,Zhang Liulu3ORCID,Chen Yuanqi4ORCID,Lin Yingyi5ORCID,Cheng Minyi3ORCID,Zheng Xingxing4ORCID,Zhuang Xiaosheng6ORCID,Wang Kun23ORCID

Affiliation:

1. Department of The First Clinical Medicine, Guangdong Medical University, Zhanjiang, China.

2. Department of Breast Cancer, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Guangdong Medical University, Guangzhou, China.

3. Department of Breast Cancer, Cancer Centre, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

4. Department of Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

5. Department of Clinical Medicine, Shantou University Medical College, Shantou, China.

6. Department of Cell and Molecular Biology, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong.

Funder

National Natural Science Foundation of China

Deng Feng project of high-level hospital construction

Basic and Applied Basic Research Foundation of Guangdong Province

Guangzhou Science and Technology Project

Fundo para o Desenvolvimento das Ciências e da Tecnologia

Beijing Medical Award Foundation

Beijing Science and Technology Innovation Medical Development Foundation

Publisher

XMLink

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3